Movement Disorders Unit, Sourasky Tel Aviv Medical Center
Welcome,         Profile    Billing    Logout  
 7 Trials 
11 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gurevich, Tanya
TEMPO-3, NCT04542499 / 2019-002951-40: Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations

Completed
3
507
Europe, US, RoW
Tavapadon, PF-06649751, CVL-751, Placebo
Cerevel Therapeutics, LLC
Parkinson Disease
01/24
02/24
TEMPO-1, NCT04201093 / 2019-002949-38: Fixed-Dose Trial in Early Parkinson's Disease (PD)

Active, not recruiting
3
522
Europe, Canada, US, RoW
Tavapadon, PF-06649751, CVL-751, Placebo
Cerevel Therapeutics, LLC
Parkinson Disease
09/24
10/24
NCT05126888: SCI-110 in the Treatment of Tourette Syndrome

Not yet recruiting
2
164
Europe, US, RoW
SCI-110, Placebo
SciSparc
Tourette Syndrome
08/25
12/25
LUMA, NCT05348785: A Study to Assess the Safety of BIIB122 Tablets and if it Can Slow the Worsening of Early-Stage Parkinson's Disease in Participants Between the Ages of 30 and 80

Recruiting
2
640
Europe, Canada, Japan, US, RoW
BIIB122, DNL151, BIIB122-Matching Placebo
Biogen, Denali Therapeutics Inc.
Parkinson Disease
12/25
12/25
NCT05822908 / 2022-001314-19: A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD

Recruiting
1/2
65
Europe, RoW
VO659
Vico Therapeutics B. V., VICO Therapeutics B.V.
Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 3, Huntington Disease
09/25
09/25
NCT05160558: A Pharmacokinetics and Safety Study of BIIB132 in Adults With Spinocerebellar Ataxia 3

Terminated
1
8
Europe, US, RoW
BIIB132, BIIB132-Matching Placebo
Biogen
Spinocerebellar Ataxia Type 3
07/23
07/23
FEEMSA, NCT04706234: Systematic Assessment of Laryngopharyngeal Function in Patients With MSA, PD, and 4repeat Tauopathies

Recruiting
N/A
200
Europe, Japan, RoW
Kliniken Beelitz GmbH, University Hospital Muenster, Medical University of Warsaw, University Hospital Carl Gustav Carus, University of Ulm, Medical University Innsbruck, Hannover Medical School, University of Barcelona
Multiple System Atrophy, Parkinson Disease, Progressive Supranuclear Palsy
12/23
07/24
NCT05795023: A Longitudinal Evaluation of Oculometric Measures and Clinical Assessment Over Time in PD Patients

Recruiting
N/A
30
RoW
NeuraLight
NeuraLight
Parkinson Disease
02/24
03/24
ROPAD, NCT03866603: Rostock International Parkinson's Disease Study

Recruiting
N/A
25000
Europe, Canada, US, RoW
CENTOGENE GmbH Rostock
Parkinson´s Disease
12/25
12/25
Ezra, Adi
NCT05698017: Study to Evaluate Investigational Allogeneic Cell Therapy Product hOMSC300 for Treatment of Early- to Moderate Stage MSA

Recruiting
1/2
18
RoW
hOMSC300, Sham Procedure
Cytora Ltd.
Multiple System Atrophy, MSA - Multiple System Atrophy
02/26
02/26
NCT05795023: A Longitudinal Evaluation of Oculometric Measures and Clinical Assessment Over Time in PD Patients

Recruiting
N/A
30
RoW
NeuraLight
NeuraLight
Parkinson Disease
02/24
03/24

Download Options